Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Orthocell Logo
Orthocell Growth Score
61
CB Rank
72024
Heat Score
65
Orthocell is a Bio-therapeutic company.
Founded
obfuscation
PublicPost-IPO Equity Melville, Western Australia, Australia11-50 orthocell.com/
Biotechnology
Medical
Therapeutics
Overview

Orthocell
Total Funding
obfuscation
Growth Score
61
Heat Score
65

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score61
-1 pts
in past quarter
Heat Score 65
24 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Orthocell

CB Rank
72024
Orthocell is a Bio-therapeutic company.
Founded
obfuscation
PublicPost-IPO Equity Melville, Western Australia, Australia11-50 orthocell.com/
Biotechnology
Medical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name ORTHOCELL LTD.
Operating Status Active
Stock Symbol  ASX:OCC
Company Type For Profit
Founders  Ming Hao Zheng, Paul Anderson
About the Company
Orthocell is a Bio-therapeutic company dedicated to improvement of the lives of people suffering from soft tissue injuries by providing innovative approaches to the regeneration of tendon, cartilage and soft tissue injuries.
Phone Number +61 8 9360 2888
Contact Email info@automic.com.au
Predictions & Insights

Growth Insight

See this Growth Insight
Orthocell is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Remplir™
A collagen-based medical device designed to support nerve repair by conforming to nerve tissue and facilitating regeneration.
Striate+™
A collagen membrane used in dental and orthopedic surgeries to support bone regeneration and tissue repair.

Research & Development

Orthocell is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
1
obfuscation
John Van Der WielenPost-IPO Equity
obfuscation
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
1
obfuscation
John Van Der WielenPost-IPO Equity
obfuscation
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
1
obfuscation
John Van Der WielenPost-IPO Equity
obfuscation
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
1
obfuscation
John Van Der WielenPost-IPO Equity
obfuscation
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
1
obfuscation
John Van Der WielenPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
1
obfuscation
John Van Der WielenPost-IPO Equity
obfuscation
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
1
obfuscation
John Van Der WielenPost-IPO Equity
obfuscation
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
1
obfuscation
John Van Der WielenPost-IPO Equity
obfuscation
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
1
obfuscation
John Van Der WielenPost-IPO Equity
obfuscation
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
1
obfuscation
John Van Der WielenPost-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Photo of John Van Der Wielen
John Van Der Wielen
Yes
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
—
Photo of John Van Der Wielen
John Van Der Wielen
Yes
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
—
Photo of John Van Der Wielen
John Van Der Wielen
Yes
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
—
Photo of John Van Der Wielen
John Van Der Wielen
Yes
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
—
Photo of John Van Der Wielen
John Van Der Wielen
Yes
Post-IPO Equity - Orthocell Logo
Post-IPO Equity - Orthocell
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 18

Employee Profiles

News

News and Press

News•Jun 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 17, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 16, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,503
108.24%
 in past month

Actively Used Products

13Orthocell uses 13 technology products and services including HTML5, Amazon EC2, and  Modernizr, according to G2 Stack.

Active Website Tech Count

33Orthocell is actively using 33 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.

Total IP

52The intellectual property of Orthocell includes 22 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Orthocell has registered 30 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Orthocell's headquarters? Orthocell is located in Melville, Western Australia, Australia.Who invested in Orthocell? Orthocell is funded by John Van Der Wielen.When was the last funding round for Orthocell? Orthocell closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Orthocell's competitors? Alternatives and possible competitors to Orthocell may include ReNerve, Cartago Biotech, and  Hyundai Bioland.How much funding has Orthocell raised to date? Orthocell has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|